Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA

Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA

To report a multi-institutional case series of patients with advanced microsatellite instability high (MSI-H) prostate adenocarcinoma identified with clinical cell-free DNA (cfDNA) next-generation sequencing (NGS) testing and treated with immune checkpoint inhibitors. Retrospective analysis of patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Neeraj Agarwal, Oliver Sartor, Brian Lewis, Hani Babiker, Elisa Ledet, Lesli Kiedrowski, Pedro Barata, Roberto Nussenzveig, Benjamin Gerendash, Ellen Jaeger, Whitley Hatton, Jodi Layton, Alan Bryce, Cy Stein, Philip Saylor
Format: Article
Language:English
Published: BMJ Publishing Group 2020-10-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001065.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jitc.bmj.com/content/8/2/e001065.full

Similar Items